Transcat, Inc. (NASDAQ:TRNS) Receives $134.50 Consensus PT from Brokerages

Transcat, Inc. (NASDAQ:TRNS) has received a consensus rating of “Moderate Buy” from the four research firms that are currently covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $142.67.

Several research analysts have issued reports on the company. HC Wainwright boosted their target price on Transcat from $124.00 to $156.00 and gave the company a “buy” rating in a research report on Wednesday. Northland Capmk downgraded Transcat from a “strong-buy” rating to a “hold” rating in a research report on Wednesday. Oppenheimer lifted their target price on Transcat from $125.00 to $160.00 and gave the stock an “outperform” rating in a research report on Wednesday. TheStreet upgraded shares of Transcat from a “c+” rating to a “b” rating in a report on Wednesday, January 31st. Finally, Northland Securities lowered shares of Transcat from an “outperform” rating to a “market perform” rating in a report on Wednesday.

Insider Transactions at Transcat

In related news, CEO Lee D. Rudow sold 12,000 shares of the company’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $135.10, for a total value of $1,621,200.00. Following the completion of the sale, the chief executive officer now directly owns 91,692 shares of the company’s stock, valued at $12,387,589.20. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, CEO Lee D. Rudow sold 3,343 shares of the business’s stock in a transaction on Monday, May 20th. The stock was sold at an average price of $124.12, for a total value of $414,933.16. Following the completion of the transaction, the chief executive officer now directly owns 103,692 shares of the company’s stock, valued at approximately $12,870,251.04. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Lee D. Rudow sold 12,000 shares of the firm’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $135.10, for a total value of $1,621,200.00. Following the sale, the chief executive officer now directly owns 91,692 shares in the company, valued at approximately $12,387,589.20. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 17,716 shares of company stock valued at $2,300,557. 4.20% of the stock is currently owned by corporate insiders.

Institutional Trading of Transcat

Several hedge funds have recently modified their holdings of the company. State Board of Administration of Florida Retirement System purchased a new position in shares of Transcat in the 3rd quarter worth approximately $207,000. Arizona State Retirement System acquired a new stake in Transcat in the third quarter valued at approximately $213,000. Virtu Financial LLC purchased a new position in Transcat in the first quarter worth $224,000. Quantbot Technologies LP increased its position in shares of Transcat by 118.2% during the third quarter. Quantbot Technologies LP now owns 2,370 shares of the scientific and technical instruments company’s stock worth $232,000 after purchasing an additional 1,284 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its holdings in shares of Transcat by 13.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,347 shares of the scientific and technical instruments company’s stock valued at $262,000 after purchasing an additional 284 shares during the last quarter. 98.34% of the stock is owned by hedge funds and other institutional investors.

Transcat Price Performance

TRNS stock opened at $134.51 on Thursday. The company has a current ratio of 3.37, a quick ratio of 2.81 and a debt-to-equity ratio of 0.01. Transcat has a 12 month low of $81.26 and a 12 month high of $147.00. The stock has a market cap of $1.19 billion, a PE ratio of 84.60 and a beta of 0.61. The company has a 50-day moving average price of $114.10 and a 200 day moving average price of $106.59.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.